What is the optimal larynx preservation approach and who are the candidates?
Jean-Louis Lefebvre (FR)
Is the approach to patients with unknown primary tumors any different in 2017?
Piero Nicolai (IT)
Cytotoxic chemotherapy and targeted therapy in nasopharynx cancer
Ethan Argiris (GR)
Are there alternative chemotherapy regimens for EXTREME in recurrent/metastatic SCCHN
Joel Guigay (FR)
New data on systemic therapy of salivary gland tumors
Lisa Licitra (IT)
Treatment of elderly patients with head and neck cancer
Jan Vermorken (BE)